Ann: Medgate extends European ResAppDx trial, page-20

Hi @AlCp, well today's the 3rd of June so exactly one month on from your RAP/RSH price call of 10c... I did say I'd check in with you, and not bring any excuses - so here I am. You were right about RSH being sub 10c. But on RAP, hmmm, another 94% increase still needed to get over that threshold. I think this demonstrates the obvious danger in making short term SP predictions.

That aside, hopefully a positive update today for RAP with the trial being extended two months. To be completely objective I'm not sure how I read the announcement as TK seems rather ebullient whereas Andy Fischer is far more cautious in his wording. I know you will be bullish, but caution seems more prudent given recent history.

But if the Medgate deal does actually come off, potentially that will give RAP some legs to run. Good luck.